{
    "xml": "<topic id=\"PHP512\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/budesonide\" basename=\"budesonide\" title=\"BUDESONIDE\">\n<title>BUDESONIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_496\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/budesonide\">Budesonide</xref>\n</p>\n<data name=\"vtmid\">108622005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" title=\"CORTICOSTEROIDS (INHALED)\" namespace=\"/drug-classes/corticosteroids-inhaled\">CORTICOSTEROIDS (INHALED)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" title=\"CORTICOSTEROIDS (INTRANASAL)\" namespace=\"/drug-classes/corticosteroids-intranasal\">CORTICOSTEROIDS (INTRANASAL)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">   </data>\r\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP40432\" outputclass=\"indicationsAndDose\" rev=\"1.89\" parent=\"/drugs/budesonide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of mild to moderate asthma (in patients stabilised on twice daily dose)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>200&#8211;400&#8239;micrograms once daily, dose to be given in the evening.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>200&#8211;400&#8239;micrograms once daily (max. per dose 800&#8239;micrograms), dose to be given in the evening.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;micrograms once daily (max. per dose 800&#8239;micrograms), dose to be given in the evening.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>100&#8211;400&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>100&#8211;800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8211;800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By inhalation of nebulised suspension</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6 months&#8211;11 years</p>\n<p>125&#8211;500&#8239;micrograms twice daily, adjusted according to response; maximum 2&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 0.25&#8211;1&#8239;mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2&#8239;mg per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 0.25&#8211;1&#8239;mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2&#8239;mg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis and treatment of allergic and vasomotor rhinitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 200&#8239;micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100&#8239;micrograms twice daily, dose to be administered to each nostril; reduced to 100&#8239;micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 200&#8239;micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100&#8239;micrograms twice daily, dose to be administered to each nostril; reduced to 100&#8239;micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nasal polyps</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>100&#8239;micrograms twice daily for up to 3 months, dose to be administered into each nostril.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8239;micrograms twice daily for up to 3 months, dose to be administered into each nostril.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"potency\">\n<title>Potency</title>\n<p>Dose adjustments may be required for some inhaler devices, see under individual preparations.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39643\" outputclass=\"unlicensedUse\" rev=\"1.16\" parent=\"/drugs/budesonide\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use or <ph outputclass=\"route\">rectal</ph> use in children</p>\n<p>Not licensed for use in children.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in children</p>\n<p>\n<i>Pulmicort</i>\n<tm tmtype=\"reg\"/>\n<i>nebuliser solution</i> not licensed for use in children under 3 months; not licensed for use in bronchopulmonary dysplasia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40808\" outputclass=\"cautions\" rev=\"1.22\" parent=\"/drugs/budesonide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With systemic use</p>\n<p>\n<ph outputclass=\"caution\">autoimmune hepatitis</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40469\" outputclass=\"hepaticImpairment\" parent=\"/drugs/budesonide\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"additionalMonitoringInHepaticImpairment\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>When used in autoimmune hepatitis liver function tests should be monitored every 2 weeks for 1 month, then at least every 3 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41064\" outputclass=\"directionsForAdministration\" rev=\"1.17\" parent=\"/drugs/budesonide\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>Budesonide nebuliser suspension is not suitable for use in ultrasonic nebulisers.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Capsules can be opened and the contents mixed with apple or orange juice.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Granules should be placed on tongue and washed down with water without chewing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59576\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.24\" parent=\"/drugs/budesonide\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of granule formulations may include lemon.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40205\" outputclass=\"patientAndCarerAdvice\" rev=\"1.36\" parent=\"/drugs/budesonide\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\r\n</p>\r\n<p>With high doses, a steroid card should be supplied.</p>\r\n<p>Patients or carers should be given advice on how to administer budesonide dry powder inhaler and nebuliser suspension.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\r\n<p>Patients or carers should be given advice on how to administer budesonide granules.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Budesonide inhaler for asthma prevention (prophylaxis)</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis\">www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP39024\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.9\" parent=\"/drugs/budesonide\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intranasal</ph> use in adults</p>\n<p>Preparations of budesonide can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of seasonal allergic rhinitis in adults over 18 years subject to max. single dose of 200&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. period of 3 months, and a pack size of 10&#8239;mg.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP512-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/budesonide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP000089\" title=\"Modified-release tablet\" namespace=\"/drugs/budesonide/modified-release-tablet\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75488\" title=\"Modified-release capsule\" namespace=\"/drugs/budesonide/modified-release-capsule\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75563\" title=\"Gastro-resistant capsule\" namespace=\"/drugs/budesonide/gastro-resistant-capsule\">Gastro-resistant capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76038\" title=\"Gastro-resistant granules\" namespace=\"/drugs/budesonide/gastro-resistant-granules\">Gastro-resistant granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75805\" title=\"Inhalation powder\" namespace=\"/drugs/budesonide/inhalation-powder\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75422\" title=\"Nebuliser liquid\" namespace=\"/drugs/budesonide/nebuliser-liquid\">Nebuliser liquid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75891\" title=\"Foam\" namespace=\"/drugs/budesonide/foam\">Foam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75652\" title=\"Enema\" namespace=\"/drugs/budesonide/enema\">Enema</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75730\" title=\"Spray\" namespace=\"/drugs/budesonide/spray\">Spray</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85580\" namespace=\"/drugs/budesonide-with-formoterol\" title=\"BUDESONIDE WITH FORMOTEROL\" count=\"1\" rel=\"backlink\">BUDESONIDE WITH FORMOTEROL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78316\" namespace=\"/treatment-summaries/inflammatory-bowel-disease\" title=\"Inflammatory bowel disease\" count=\"2\" rel=\"backlink\">Inflammatory bowel disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78318\" namespace=\"/treatment-summaries/airways-disease-use-of-corticosteroids\" title=\"Airways disease, use of corticosteroids\" count=\"1\" rel=\"backlink\">Airways disease, use of corticosteroids</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78467\" namespace=\"/treatment-summaries/respiratory-system\" title=\"Respiratory system\" count=\"1\" rel=\"backlink\">Respiratory system</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78495\" namespace=\"/treatment-summaries/nose\" title=\"Nose\" count=\"1\" rel=\"backlink\">Nose</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78519\" namespace=\"/treatment-summaries/croup\" title=\"Croup\" count=\"1\" rel=\"backlink\">Croup</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_496\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/budesonide\" title=\"Budesonide\" count=\"1\" rel=\"link\">Budesonide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" namespace=\"/drug-classes/corticosteroids-inhaled\" title=\"CORTICOSTEROIDS (INHALED)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INHALED)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" namespace=\"/drug-classes/corticosteroids-intranasal\" title=\"CORTICOSTEROIDS (INTRANASAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INTRANASAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP000089\" namespace=\"/drugs/budesonide/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75488\" namespace=\"/drugs/budesonide/modified-release-capsule\" title=\"Modified-release capsule\" count=\"1\" rel=\"link\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75563\" namespace=\"/drugs/budesonide/gastro-resistant-capsule\" title=\"Gastro-resistant capsule\" count=\"1\" rel=\"link\">Gastro-resistant capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76038\" namespace=\"/drugs/budesonide/gastro-resistant-granules\" title=\"Gastro-resistant granules\" count=\"1\" rel=\"link\">Gastro-resistant granules</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75805\" namespace=\"/drugs/budesonide/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75422\" namespace=\"/drugs/budesonide/nebuliser-liquid\" title=\"Nebuliser liquid\" count=\"1\" rel=\"link\">Nebuliser liquid</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75891\" namespace=\"/drugs/budesonide/foam\" title=\"Foam\" count=\"1\" rel=\"link\">Foam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75652\" namespace=\"/drugs/budesonide/enema\" title=\"Enema\" count=\"1\" rel=\"link\">Enema</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75730\" namespace=\"/drugs/budesonide/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n</links>\n</topic>",
    "id": "PHP512",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/budesonide",
    "basename": "budesonide",
    "title": "BUDESONIDE",
    "interactants": [
        {
            "id": "bnf_int_496",
            "label": "Budesonide"
        }
    ],
    "vtmid": "108622005",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (INHALED)",
        "CORTICOSTEROIDS (SYSTEMIC)",
        "CORTICOSTEROIDS (INTRANASAL)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of mild to moderate asthma (in patients stabilised on twice daily dose)",
                        "html": "Prophylaxis of mild to moderate asthma (in patients stabilised on twice daily dose)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of powder"
                    ],
                    "textContent": "By inhalation of powder",
                    "html": "By inhalation of powder"
                },
                "child": [
                    {
                        "textContent": "200&#8211;400 micrograms once daily, dose to be given in the evening.",
                        "html": "<p>200&#8211;400&#8239;micrograms once daily, dose to be given in the evening.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "200&#8211;400 micrograms once daily (max. per dose 800 micrograms), dose to be given in the evening.",
                        "html": "<p>200&#8211;400&#8239;micrograms once daily (max. per dose 800&#8239;micrograms), dose to be given in the evening.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200&#8211;400 micrograms once daily (max. per dose 800 micrograms), dose to be given in the evening.",
                        "html": "<p>200&#8211;400&#8239;micrograms once daily (max. per dose 800&#8239;micrograms), dose to be given in the evening.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of asthma",
                        "html": "Prophylaxis of asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of nebulised suspension"
                    ],
                    "textContent": "By inhalation of nebulised suspension",
                    "html": "By inhalation of nebulised suspension"
                },
                "child": [
                    {
                        "textContent": "100&#8211;400 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>100&#8211;400&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "100&#8211;800 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>100&#8211;800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>",
                        "ageGroup": "12&#8211;17 years"
                    },
                    {
                        "textContent": "125&#8211;500 micrograms twice daily, adjusted according to response; maximum 2 mg per day.",
                        "html": "<p>125&#8211;500&#8239;micrograms twice daily, adjusted according to response; maximum 2&#8239;mg per day.</p>",
                        "ageGroup": "6 months&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 0.25&#8211;1 mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2 mg per day.",
                        "html": "<p>Initially 0.25&#8211;1&#8239;mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2&#8239;mg per day.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "100&#8211;800 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>100&#8211;800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>"
                    },
                    {
                        "textContent": "Initially 0.25&#8211;1 mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2 mg per day.",
                        "html": "<p>Initially 0.25&#8211;1&#8239;mg twice daily, adjusted according to response, doses higher than recommended max. may be used in severe disease; maximum 2&#8239;mg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis and treatment of allergic and vasomotor rhinitis",
                        "html": "Prophylaxis and treatment of allergic and vasomotor rhinitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "child": [
                    {
                        "textContent": "Initially 200 micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100 micrograms twice daily, dose to be administered to each nostril; reduced to 100 micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.",
                        "html": "<p>Initially 200&#8239;micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100&#8239;micrograms twice daily, dose to be administered to each nostril; reduced to 100&#8239;micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 200 micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100 micrograms twice daily, dose to be administered to each nostril; reduced to 100 micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.",
                        "html": "<p>Initially 200&#8239;micrograms daily, dose to be administered into each nostril in the morning, alternatively initially 100&#8239;micrograms twice daily, dose to be administered to each nostril; reduced to 100&#8239;micrograms daily, dose to be administered into each nostril, dose can be reduced when control achieved.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nasal polyps",
                        "html": "Nasal polyps"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "child": [
                    {
                        "textContent": "100 micrograms twice daily for up to 3 months, dose to be administered into each nostril.",
                        "html": "<p>100&#8239;micrograms twice daily for up to 3 months, dose to be administered into each nostril.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "100 micrograms twice daily for up to 3 months, dose to be administered into each nostril.",
                        "html": "<p>100&#8239;micrograms twice daily for up to 3 months, dose to be administered into each nostril.</p>"
                    }
                ]
            }
        ],
        "potency": [
            {
                "type": "potency",
                "title": "Potency",
                "textContent": "Dose adjustments may be required for some inhaler devices, see under individual preparations.",
                "html": "<p>Dose adjustments may be required for some inhaler devices, see under individual preparations.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral use or rectal use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use or <ph outputclass=\"route\">rectal</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral",
                        "rectal"
                    ]
                },
                "textContent": "Not licensed for use in children.",
                "html": "<p>Not licensed for use in children.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by inhalation in children",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Pulmicort nebuliser solution not licensed for use in children under 3 months; not licensed for use in bronchopulmonary dysplasia.",
                "html": "<p>\n<i>Pulmicort</i>\n<tm tmtype=\"reg\"/>\n<i>nebuliser solution</i> not licensed for use in children under 3 months; not licensed for use in bronchopulmonary dysplasia.</p>"
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "autoimmune hepatitis in adults",
                "html": "autoimmune hepatitis in adults",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "hepaticImpairment": {
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "When used in autoimmune hepatitis liver function tests should be monitored every 2 weeks for 1 month, then at least every 3 months.",
                "html": "<p>When used in autoimmune hepatitis liver function tests should be monitored every 2 weeks for 1 month, then at least every 3 months.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Budesonide nebuliser suspension is not suitable for use in ultrasonic nebulisers.",
                "html": "<p>Budesonide nebuliser suspension is not suitable for use in ultrasonic nebulisers.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Capsules can be opened and the contents mixed with apple or orange juice.",
                "html": "<p>Capsules can be opened and the contents mixed with apple or orange juice.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Granules should be placed on tongue and washed down with water without chewing.",
                "html": "<p>Granules should be placed on tongue and washed down with water without chewing.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of granule formulations may include lemon.",
                "html": "<p>Flavours of granule formulations may include lemon.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "With high doses, a steroid card should be supplied.\n\nPatients or carers should be given advice on how to administer budesonide dry powder inhaler and nebuliser suspension.",
                "html": "<p>With high doses, a steroid card should be supplied.</p><p>Patients or carers should be given advice on how to administer budesonide dry powder inhaler and nebuliser suspension.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer budesonide granules.",
                "html": "<p>Patients or carers should be given advice on how to administer budesonide granules.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis",
                        "label": "www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Budesonide inhaler for asthma prevention (prophylaxis)",
                "textContent": "www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis\">www.medicinesforchildren.org.uk/budesonide-inhaler-asthma-prevention-prophylaxis</xref>\n</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With intranasal use in adults",
                    "html": "With <ph outputclass=\"route\">intranasal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intranasal"
                    ]
                },
                "textContent": "Preparations of budesonide can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of seasonal allergic rhinitis in adults over 18 years subject to max. single dose of 200 micrograms per nostril, max. daily dose of 200 micrograms per nostril for max. period of 3 months, and a pack size of 10 mg.",
                "html": "<p>Preparations of budesonide can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of seasonal allergic rhinitis in adults over 18 years subject to max. single dose of 200&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. period of 3 months, and a pack size of 10&#8239;mg.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP000089",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75488",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75563",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76038",
                "label": "Gastro-resistant granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75805",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75422",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75891",
                "label": "Foam",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75652",
                "label": "Enema",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75730",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85580",
                "label": "BUDESONIDE WITH FORMOTEROL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78316",
                "label": "Inflammatory bowel disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78318",
                "label": "Airways disease, use of corticosteroids",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78467",
                "label": "Respiratory system",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78495",
                "label": "Nose",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78519",
                "label": "Croup",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_496",
                "label": "Budesonide",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34650",
                "label": "CORTICOSTEROIDS (INHALED)",
                "type": "drugClass"
            },
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            },
            {
                "id": "PHP34648",
                "label": "CORTICOSTEROIDS (INTRANASAL)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP000089",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75488",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75563",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76038",
                "label": "Gastro-resistant granules",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75805",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75422",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75891",
                "label": "Foam",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75652",
                "label": "Enema",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75730",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    }
}